Cargando…

Barriers to alcohol and other drug treatment use among Black African and Coloured South Africans

BACKGROUND: There are racial disparities in the use of alcohol and other drug (AOD) treatment services in South Africa but little is known about the factors contributing to these disparities. This study aimed to redress this gap through identifying differences in barriers to AOD treatment use among...

Descripción completa

Detalles Bibliográficos
Autor principal: Myers, Bronwyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658894/
https://www.ncbi.nlm.nih.gov/pubmed/23683119
http://dx.doi.org/10.1186/1472-6963-13-177
_version_ 1782270356561592320
author Myers, Bronwyn
author_facet Myers, Bronwyn
author_sort Myers, Bronwyn
collection PubMed
description BACKGROUND: There are racial disparities in the use of alcohol and other drug (AOD) treatment services in South Africa but little is known about the factors contributing to these disparities. This study aimed to redress this gap through identifying differences in barriers to AOD treatment use among Black African and Coloured persons from Cape Town, South Africa. The Behavioral Model of Health Services Utilization was used as an analytic framework. METHODS: A case-control design was used to compare 434 individuals with AOD problems who had accessed treatment with 555 controls who had not accessed treatment on a range of variables. Logistic regression procedures were employed to examine the unique profile of variables associated with treatment utilization for Black African and Coloured participants. RESULTS: After controlling for the influence of treatment need and predisposing factors on treatment use, several barriers to treatment were identified. Greater awareness of treatment options and fewer geographic access and affordability barriers were strongly associated with an increased likelihood of AOD treatment use for both race groups. However, Black African persons were more vulnerable to the effects of awareness and geographic access barriers on treatment use. Stigma consciousness was only associated with AOD treatment utilization for Coloured participants. CONCLUSION: Differences in barriers to AOD treatment use were found among Black African and Coloured South Africans. Targeted interventions that address the unique profile of barriers experienced by each race group are needed to improve AOD treatment use by these underserved groups. Several strategies for improving the likelihood of treatment entry are suggested.
format Online
Article
Text
id pubmed-3658894
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36588942013-05-21 Barriers to alcohol and other drug treatment use among Black African and Coloured South Africans Myers, Bronwyn BMC Health Serv Res Research Article BACKGROUND: There are racial disparities in the use of alcohol and other drug (AOD) treatment services in South Africa but little is known about the factors contributing to these disparities. This study aimed to redress this gap through identifying differences in barriers to AOD treatment use among Black African and Coloured persons from Cape Town, South Africa. The Behavioral Model of Health Services Utilization was used as an analytic framework. METHODS: A case-control design was used to compare 434 individuals with AOD problems who had accessed treatment with 555 controls who had not accessed treatment on a range of variables. Logistic regression procedures were employed to examine the unique profile of variables associated with treatment utilization for Black African and Coloured participants. RESULTS: After controlling for the influence of treatment need and predisposing factors on treatment use, several barriers to treatment were identified. Greater awareness of treatment options and fewer geographic access and affordability barriers were strongly associated with an increased likelihood of AOD treatment use for both race groups. However, Black African persons were more vulnerable to the effects of awareness and geographic access barriers on treatment use. Stigma consciousness was only associated with AOD treatment utilization for Coloured participants. CONCLUSION: Differences in barriers to AOD treatment use were found among Black African and Coloured South Africans. Targeted interventions that address the unique profile of barriers experienced by each race group are needed to improve AOD treatment use by these underserved groups. Several strategies for improving the likelihood of treatment entry are suggested. BioMed Central 2013-05-17 /pmc/articles/PMC3658894/ /pubmed/23683119 http://dx.doi.org/10.1186/1472-6963-13-177 Text en Copyright © 2013 Myers; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Myers, Bronwyn
Barriers to alcohol and other drug treatment use among Black African and Coloured South Africans
title Barriers to alcohol and other drug treatment use among Black African and Coloured South Africans
title_full Barriers to alcohol and other drug treatment use among Black African and Coloured South Africans
title_fullStr Barriers to alcohol and other drug treatment use among Black African and Coloured South Africans
title_full_unstemmed Barriers to alcohol and other drug treatment use among Black African and Coloured South Africans
title_short Barriers to alcohol and other drug treatment use among Black African and Coloured South Africans
title_sort barriers to alcohol and other drug treatment use among black african and coloured south africans
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658894/
https://www.ncbi.nlm.nih.gov/pubmed/23683119
http://dx.doi.org/10.1186/1472-6963-13-177
work_keys_str_mv AT myersbronwyn barrierstoalcoholandotherdrugtreatmentuseamongblackafricanandcolouredsouthafricans